Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM Trial
ConclusionsTDM-guided dose optimization of tamoxifen is estimated to save costs and increase QALYs for early breast cancer patients.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Drugs & Pharmacology | Healthcare Costs | Netherlands Health | Tamoxifen